A test in context: lipoprotein(a)
Tsimikas S. J Am Coll Cardiol
Down to the genome.
Up to you.
Bioscope.ai is the precision longevity platform that takes the shape of your practice.
Combine whole-genome sequencing with every record, lab, scan and wearable. Outputs and action plans come back cited, matched to how you practice the art of medicine. You decide the plan and what your patient sees.
Product tour
Pull up a chart and look around.
See what Bioscope.ai looks like inside. A self-guided walkthrough of the product. No sign-up, no sales call.
Eleanor VanceFemale · 58 years · 5’6” · 148 lbBP128/78A1c5.8%ApoB96Whole genomeLabs, 11 yearsMicrobiomeImagingMedicationsWearables
What Is Bioscope.ai?
Patients are asking their doctors about longevity earlier than ever. They want an answer measured in decades, and they bring more labs, imaging and wearable data than anyone can work through by hand. Most software either gathers the data or tries to be the doctor. Bioscope.ai works through all of it with you, shows its evidence, and leaves the medicine to you.
Explore bioscope.ai
Don Brown, MD
Founder and CEO
Helen Messier, MD, PhD
Chief Medical Officer
Everything about the patient. From the genome to what they tell you in the room.
Inputs are more powerful together than one at a time. The genome explains what the labs keep showing. Wearables give an image a timeline. The visit changes what the microbiome means. Considered together, they describe this patient rather than a population average.
- 01The whole genome, not a 90-gene panel.Sequenced once, included in the price, then considered against new research for the rest of their life.
- 02Records and labsEvery panel you have ordered, plus the ones you inherited. Any provider, any format, any year.
- 03ImagingNeuro-volumetrics, brain age, whole-body MRI organ analysis, coronary CT, DEXA scored against population norms, integrated with labs and functional data, not in a seperate portal.
- 04WearablesSleep, training load and glucose from the 362 days you don't see them, rather than just the three you do.
- 05MicrobiomeComposition and function, mapped against what they actually eat and the supplements they take. The microbiome changes and those changes matter.
- 06The visit is still where the most useful information comes from.Maybe it's a new job, poor sleep, or stresses at home. These inputs change what you decide to do next.
Eleanor Vance
Inputs1
The whole genome, not a
90-gene panel.Whole genome3.2B base pairs
90-gene panel.Whole genome3.2B base pairs
Records and labsLabs and history148 panels · 11 yrs
ImagingStudies on file6 studies
WearablesContinuous streams312 days
MicrobiomeShotgun Metagenomic2 samples
The visit is still where the most useful information comes from.From the visitIn the room
You've built a way of practicing. Bioscope.ai runs on it.
Longevity and concierge doctors don't all practice alike. Your method is why your patients chose you, so it's worth protecting. Bioscope.ai takes its shape.
Your clinical reasoning framework
Upload a protocol, a patient-facing deck, or a recording of you talking through a case. Those become the rules Bioscope.ai works from: when Lp(a) gets screened, what counts as an ApoB target, which risks you treat a decade early.
Your prompts and protocols
The standing questions your practice asks in every chart, and the reports you run on every patient. They are saved once, applied to your entire panel, and never retyped.
Your thresholds, your numbers and your language
If you want to be notified about an ApoB target under 60, that notification can happen across your panel and records.
How do you want to see your patient?
Four healthspan scores? A biological age front and center? Organ system scorecards or a spider chart across domains? Ask for the view you want and it's on every chart in your panel.
Your practice
Aggressive prevention
Eleanor Vance, 58
Member since 2019 · genome, 11 years of labs, coronary CT, microbiome, wearables
Threshold
ApoB target < 60 mg/dL, Lp(a) screened at intake
Language
“Lifetime atherogenic exposure”, staged by decade
Cadence
Quarterly labs, annual imaging
What the patient is told
- Start pravastatin 40 mg, recheck ApoB at 8 weeks
- Add Lp(a)-directed review at the next annual
- Screen both adult children for Lp(a)
Why not just use a consumer LLM?
Both answer in seconds. Only one of them can take a 100GB genome.
Consumer LLM
Bioscope.aiThe patient record
A conversation that ends and nothing accumulates.
A patient record that keeps growing for as long as they are yours.
How much it can hold
A few files at a time. There's a hard limit on what one conversation can hold, and a 100 GB genome is orders of magnitude past it.
No ceiling on patient context you can provide: whole genome, imaging, wearables, data records, and microbiome, all in one record and considered together.
What the answer is built on
The open web, including forums and blogs that sit alongside formal literature without a way to tell which is which.
Peer-reviewed literature and this patient's own data, with a citation behind every finding.
Asked again next month
Reword the question and the answer changes. Ask as a different user and you get a different result.
A deterministic answer. The same record, the same question, the same answer. And multiple models check each other before anything reaches you.
Whose art of medicine it follows
A general standard of care. Someone's, but not yours.
Your protocols, your thresholds, your language, and your way of showing health to a patient.
Getting the data in
You find it, you upload it, every time.
EHR and wearables integrations, plus sequencing, imaging and microbiome testing ordered through Bioscope.ai or its partners.
Getting insights to the patient
Copy, paste, reformat and hope it shares right.
Share the report or action plan from inside the record, once you've approved it.
We make our AI show its work.
Everything about the patient goes in. What comes out can be traced to the record it came from, and to the published paper behind it.
Everything on Eleanor
Whole genome3.2B base pairs
Labs and records148 panels · 11 yrs
ImagingCoronary CT, DEXA
Wearables312 days
Microbiome2 samples
The visit itselfIn the room
The papers behind it
ESC/EAS Guidelines for the management of dyslipidaemias
Mach F, et al. Eur Heart J
CPIC guideline for SLCO1B1 and statin-associated musculoskeletal symptoms
Cooper-DeHoff RM, et al. Clin Pharmacol Ther
Eleanor Vance
58
Lipoprotein(a) is the dominant driver here, and it will not move with diet or a statin.
Lp(a), measured twice142 nmol/L
LPA risk genotypePresent
ApoB on treatment96 mg/dL
Tsimikas, 2017Mach et al., 2020CPIC SLCO1B1
We’ve talked about precision medicine for years, but with Bioscope.ai it’s finally here. Every clinical decision can be informed by a patient’s genome and tailored to his or her unique physiology.
You walk in ready. You walk out done.
Bioscope.ai prepares you for the visit, answers questions in the room, and drafts the follow-up action plan. You decide the plan and present it. Your method doesn't change. Your reach does.
Before the visit
Lp(a) 142 nmol/L, never addressed
Genetically set. Two adult children unscreened.
ApoB up for the third draw running
71 → 84 → 96 mg/dL since 2021.
SLCO1B1 *5 carrier
Changes which statin, not whether to treat.
Sleep down 46 minutes since January
Worth raising. Tracks with a new travel schedule.
After the visit
Action plan
Eleanor Vance, next 90 days
01
Start pravastatin 40 mg nightly
Chosen over rosuvastatin because of your SLCO1B1 result.
02
Repeat ApoB and Lp(a) in eight weeks
Lab order is already in. No fasting needed.
03
Zone 2 work, three sessions a week
Forty minutes, conversational pace. Your ring will log it.
04
Ask your two children to test Lp(a)
It is inherited. One blood draw settles it for life.
Approve and send
Pricing
Per patient, per year, sequencing included
- One annual fee per enrolled patient. You know the cost before you enroll them.
- Whole-genome sequencing is in the price. Sequenced once, never billed again.
- It fits how you already bill. Inside a membership, or cash-pay alongside it.
- Nothing per seat, nothing per report. Your whole team, on every enrolled patient.
Trust
Bulit to the standard patients are paying for
- HIPAA-compliant infrastructure that is encrypted end to end, audit-logged, and under a signed BAA.
- The patient owns their data. We never sell it and we never license it.
- Your data stays your data. It is not training material.
- Nothing is shared across practices. Your patients' records stay inside your practice.
See it on the patient you know best. You.
Your own whole genome, sequenced and loaded, with full access to everything you’d see on one of your patients.